Literature DB >> 16650465

Gonadal steroid regulation of mood: the lessons of premenstrual syndrome.

David R Rubinow1, Peter J Schmidt.   

Abstract

New models for menstrual cycle-related mood disorders provide unique opportunities to gain insight into the processing of emotional information and the regulation of mood state by reproductive steroids. This paper reviews the role of reproductive steroids in affect regulation and in premenstrual dysphoric disorder (PMD), parses PMD into component processes that suggest potential mediating neurocircuitry, and highlights the importance of and potential contributors to the differential sensitivity that permits reproductive steroids to destabilize mood in some but not all women.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16650465     DOI： 10.1016/j.yfrne.2006.02.003

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN： 0091-3022            Impact factor:   8.606


  40 in total

1.  Developmental associations between adolescent change in depressive symptoms and menstrual-cycle-phase-specific negative affect during early adulthood.

Authors:  Jeff Kiesner; François Poulin
Journal:  J Youth Adolesc       Date:  2011-10-16

2.  5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.

Authors:  Pedro E Martinez; David R Rubinow; Lynnette K Nieman; Deloris E Koziol; A Leslie Morrow; Crystal E Schiller; Dahima Cintron; Karla D Thompson; Khursheed K Khine; Peter J Schmidt
Journal:  Neuropsychopharmacology       Date:  2013-08-14       Impact factor: 7.853

3.  Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder.

Authors:  Andrea J Rapkin; Steven M Berman; Mark A Mandelkern; Daniel H S Silverman; Melinda Morgan; Edythe D London
Journal:  Biol Psychiatry       Date:  2010-11-18       Impact factor: 13.382

4.  Premenstrual dysphoric disorder: burden of illness and treatment update.

Authors:  Teri Pearlstein; Meir Steiner
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

Review 5.  Transdermal estradiol for postpartum depression: a promising treatment option.

Authors:  Eydie L Moses-Kolko; Sarah L Berga; Brinda Kalro; Dorothy K Y Sit; Katherine L Wisner
Journal:  Clin Obstet Gynecol       Date:  2009-09       Impact factor: 2.190

Review 6.  Oestrogen receptor beta is involved in the actions of oestrogens in the brain for affective behaviour, but not trophic effects in peripheral tissues.

Authors:  A A Walf
Journal:  J Neuroendocrinol       Date:  2009-12-15       Impact factor: 3.627

Review 7.  Hormonal Contraceptives and Mood: Review of the Literature and Implications for Future Research.

Authors:  Thalia Robakis; Katherine E Williams; Lexi Nutkiewicz; Natalie L Rasgon
Journal:  Curr Psychiatry Rep       Date:  2019-06-06       Impact factor: 5.285

8.  Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.

Authors:  Peter J Schmidt; Pedro E Martinez; Lynnette K Nieman; Deloris E Koziol; Karla D Thompson; Linda Schenkel; Paul G Wakim; David R Rubinow
Journal:  Am J Psychiatry       Date:  2017-04-21       Impact factor: 18.112

9.  Activity of protein kinase C is important for 3alpha,5alpha-THP's actions at dopamine type 1-like and/or GABAA receptors in the ventral tegmental area for lordosis of rats.

Authors:  Cheryl A Frye; Alicia A Walf
Journal:  Brain Res Bull       Date:  2008-07-31       Impact factor: 4.077

Review 10.  Blood oxygenation level dependent functional magnetic resonance imaging: current and potential uses in obstetrics and gynaecology.

Authors:  K Vincent; J Moore; S Kennedy; I Tracey
Journal:  BJOG       Date:  2009-01       Impact factor: 6.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.